MOG and myeloid sarcoma: The beneficial effects of fingolimod on the course of EAE extend previous reports on the efficacy in acute and relapsing rodent animal models of MS [20–22]; as well as chronic MOG-EAE models in DA rats and C57BL/6 mice [23,24].